GO
Loading...

Baxter International Inc

More

  • Weekly Jobless Claims Could Be Huge for Markets Wednesday, 17 Apr 2013 | 9:47 PM ET
    A job-seeker (top) hands his resume to Candice Perkins, a representatvie of Workforce1 during a 'Work Search' event aimed at older unemployed people in New York City.

    Weekly jobless claims will be more important than usual for markets Thursday, after an uneven series of claims reports this month and a surprisingly weak March employment report.

  • 5 Health-Care Stocks Triggering 'Buys' This Week Wednesday, 20 Feb 2013 | 12:19 PM ET

    While the S&P 500 has climbed 11.75 percent in the past three months, the health care sector has only managed to muster a 2.3 percent climb over the same time period. But underperformance tends to be cyclical.

  • Best Move of the Year? Playing the Flu Tuesday, 29 Jan 2013 | 12:45 PM ET
    A man is given a flu shot by at the medical offices of Yaffe Ruden & Associates in New York.

    Amid all the bullishness about stocks this year, the swine flu play may be getting lost. Yes, one of the most effective strategies has been betting on shares of companies that benefit from the higher-than-expected flu cases.

  • Will Tech Earnings Charge Up the Stock Market Rally? Friday, 18 Jan 2013 | 8:33 PM ET
    Google Maps app for Apple ios.

    A flood of earnings reports, including major technology and industrial companies, could make or break the stock market’s surprise January rally in the week ahead.

  • Ryan: Is the Health Care Sector 'Healthy?' Monday, 7 Jan 2013 | 2:13 PM ET

    CNBC Contributor Barbara Ryan is taking the pulse of health care stocks at this year's "Woodstock" of health care.

  • Stocks finished slightly lower across the board Tuesday after wavering in a narrow range for most of the session as investors remained cautious amid the ongoing "fiscal cliff" discussions in Washington.

  • Baxter International Inc. in Toronto, Canada.

    Drug maker Baxter International said it will buy privately held Swedish company Gambro for about $2.76 billion to broaden its dialysis product portfolio.

  • Stocks to Watch: AZO, BIG, BAX & More Tuesday, 4 Dec 2012 | 7:48 AM ET

    Take a look at some of Tuesday's morning movers.

  • *Biogen hemophilia A drug effective in trial. BOSTON, Oct 31- Biogen Idec Inc said on Wednesday its experimental treatment for patients with hemophilia A, a disorder that inhibits coagulation of the blood, controlled bleeding with fewer treatments in a late-stage clinical trial. Glenn Pierce, Chief Medical Officer for Biogen's hemophilia program.

  • Early Glance: Pharmaceuticals companies Tuesday, 23 Oct 2012 | 12:10 AM ET

    Baxter International Inc. fell$. 82 or 1.3 percent, to $61.16. Bristol-Myers Squibb Co. fell$. 68 or 2.0 percent, to $33.36. Johnson& Johnson fell$. 82 or 1.1 percent, to $70.96.

  • Earnings roundup: Morgan Stanley, Philip Morris Thursday, 18 Oct 2012 | 2:52 PM ET

    Among the earnings stories for Thursday, Oct. 18, from AP Business News:. _ Morgan Stanley reported higher revenue and net income for its third quarter thanks to gains in its bonds and asset management businesses.

  • Baxter 3Q earnings meet Wall Street estimates Thursday, 18 Oct 2012 | 1:27 PM ET

    DEERFIELD, Ill.-- Drug and medical device maker Baxter International reported third-quarter results Thursday that edged 1 percent higher as the company trimmed expenses, meeting Wall Street expectations. The company's profit rose slightly to $583 million, or $1.06 per share, from $576 million, or $1.01 per share, in the prior-year period.

  • Oct 11- Baxter International Inc:. *PiperJaffray raises Baxter International price target to $73 from. Reuters Station users, click. 1568.

  • Oct 10- Baxter International Inc:. *Barclays raises Baxter International Inc price target to $63 from. Reuters Station users, click. 1568.

  • Oct 9- Baxter International Inc:. *Says expects to increase sales approximately 5 percent over its five-year long-range plan. *Sees generating cash flow from operations of approximately $4.5 billion by the year 2017.

  • Alzheimer drug shows some promise in mild disease Monday, 8 Oct 2012 | 1:33 PM ET

    Detailed results were revealed for the first time Monday at an American Neurological Association conference in Boston. "It's certainly not the home run we all wanted, but we're very encouraged by these results," said Maria Carillo, chief science officer for the Alzheimer's Association, which had no role in the research.

  • Stocks to Watch: FDX, WAG, ORCL & More Tuesday, 19 Jun 2012 | 7:50 AM ET

    Take a look at some of Tuesday’s morning movers:

  • Lightning Round: Exelixis, Oracle, Kohl's and More Tuesday, 27 Mar 2012 | 7:50 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • What's Shaking: Friday's Early Movers Friday, 20 Jan 2012 | 8:31 AM ET

    Happy Friday! Take a look at some of this morning's early movers:

  • Most Recommended Stocks for 2012 Thursday, 5 Jan 2012 | 5:01 PM ET
    United Technologies Research Center

    Culled from thousands of pages of 2012 outlook reports, 13 stocks are being called “The Most Recommended Stocks for 2012”, according to a new report from Birinyi Associates.